Pendulum

San Francisco, United States Founded: 2012 • Age: 14 yrs
Pendulum is focused on developing advanced probiotic solutions.

About Pendulum

Pendulum is a Healthcare company based in San Francisco (United States) founded in 2012 by Jim Bullard. Pendulum is focused on developing advanced probiotic solutions. It operates on a Direct-to-Consumer (D2C) and Subscription Services model. Pendulum has raised $109.5 million across 5 funding rounds from investors including Mayo Clinic, Khosla Ventures and Fonterra. The company has 55 employees. Its website pendulumlife.com draws about 265 thousand monthly visits. Pendulum offers products and services including Metabolic Daily, Akkermansia, Glucose Control, and Polyphenol Booster. Its focus areas include Biotechnology and Microbiome Solutions. Its competitors include Sana Biotechnology, Semma Therapeutics and Rezolute; 2 of its 3 listed competitors have raised funding.

Company details

Pendulum is engaged in the development of next-generation probiotics aimed at improving whole-body health through gut microbiome transformation. The company operates in the healthcare and biotechnology sector, offering specialized products like Metabolic Daily, Akkermansia, Glucose Control, and Polyphenol Booster. Solutions are backed by scientific research from PhD doctors and scientists, with clinical efficacy demonstrated in products like Glucose Control for type 2 diabetes management. Partnerships with institutions such as the Mayo Clinic and rigorous in-house research further support their innovative approach to microbiome solutions.

  • Headquarters San Francisco, United States
  • Employees 55
  • Founders Jim Bullard
  • Sectors
    Healthcare
  • Website category Health · Health Conditions and Concerns
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website pendulumlife.com
  • Social LinkedIn X Facebook
Key Metrics
  • Total Equity Funding
    $109.5M (USD)

    in 5 rounds

  • Latest Funding Round
    $10M (USD), Series C

    Jun 2023

  • Investors
  • Employee Count
    55

Products & Services of Pendulum

Pendulum offers a comprehensive portfolio of products and services, including Metabolic Daily, Akkermansia, Glucose Control, and Polyphenol Booster.

Metabolic Daily
Probiotics

Metabolism is improved through targeted probiotic strains daily.

Akkermansia
Probiotics

Gut health is supported by replenishing keystone strains.

Glucose Control
Probiotics

Glucose spikes and A1C levels are lowered effectively.

Polyphenol Booster
Probiotics

Antioxidants are increased to protect cells from damage.

Funding Insights of Pendulum

Pendulum has successfully raised a total of $109.5M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $109.5M
  • Total Rounds 5
  • Last Round Series C β€” $10M
  • First Round $10.5M

    (Jun 2017)

  • Investors Count 8

All 5 funding rounds of Pendulum with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2023$10MSeries C–Fonterra
–
Feb 2023Angel Round–Halle Berry
–
Apr 2021$54MSeries C–Meritech
May 2019$35MSeries B–Sequoia Capital
Jun 2017$10.5MSeries A––
–
Valuation history

8 investors in total: 7 institutional and 1 angel.

Investors in Pendulum

Pendulum has secured backing from 8 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Mayo Clinic, Khosla Ventures and Fonterra.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Private equity investments are directed toward US-based companies.
meritechcapital.comPalo Alto, United States
Sequoia Capital is engaged in venture capital investments.
1972sequoiacap.com
Venture capital firm supporting AI founders through investments and community.
trueventures.com
Early-stage startups are funded by this venture capital firm.
2004khoslaventures.comMenlo Park, United States
AME Cloud Ventures is focused on investing in data-driven technology companies.
amecloudventures.comPalo Alto, United States
Dairy products including milk powder, cheese, and butter are produced.
2001fonterra.comAuckland, New Zealand
General medical clinics are operated throughout the United States.
1864mayoclinic.orgUnited States

Halle Berry

unknown_7acb8dac8f8746459
Premium access

Investor details for Pendulum

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Pendulum

51 people are tracked at Pendulum (11 in leadership, 17 in board & advisors, 23 in team); the tracked headcount is 55.

NameRoleGroup
Jim Bullard
CTO & Co-FounderLeadership
Esther Yu, Ph.D.
VP, Regulatory AffairsLeadership
Colleen Cutcliffe
CEOLeadership
Andrey Reznik
Chief Financial OfficerLeadership
David Raksin
VP, Strategic FinanceLeadership
Chase Motley
Director of FinanceLeadership
Brian Minnie
Vice President Information TechnologyLeadership
Orville Kolterman
Chief Medical OfficerLeadership
Adam Perlman
Chief Medical OfficerLeadership
Marin Thompson
Director, Clinical StudiesLeadership
Jocelyn Woolsey
Vice President, RevenueLeadership
Craig Sherman
DirectorBoard & advisors
Heather Mason
DirectorBoard & advisors
Hugh Martin
DirectorBoard & advisors
Peter Barton Hutt
DirectorBoard & advisors
Roelof Botha
DirectorBoard & advisors
Alfred Spormann
Scientific AdvisorBoard & advisors
Anne Peters
Medical AdvisorBoard & advisors
Davida Krueger
Medical AdvisorBoard & advisors
Peter Turnbaugh
Scientific AdvisorBoard & advisors

31 more people are available in the full profile.

Premium access

Complete people profiles for Pendulum

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Pendulum

3 dated milestones of Pendulum across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pendulum is founded.
  2. Funding First funding round of $10.5M.
  3. Funding Latest funding round, Series C, of $10.0M.

Competitors of Pendulum

Pendulum has 3 listed competitors in our database, 2 of them funded. They include Sana Biotechnology, Semma Therapeutics and Rezolute.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
sana.com2018Seattle, United States$821M328
Genetically engineered cell therapies are developed for multiple disorders.
semma-tx.com2015Cambridge, United States$158M58
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
rezolutebio.com2012Denver, United States51
Therapies for metabolic and orphan diseases are developed by Rezolute.
Premium access

Detailed competitors of Pendulum

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Pendulum

The website of Pendulum (pendulumlife.com) receives about 265.4K visits a month and ranks #162,384 among all websites worldwide, #5,101 in Health Conditions and Concerns.

  • Monthly visits
    265.4K

    ▲ 18.2% vs previous month

  • Unique visitors
    118.1K

    per month

  • Global rank
    #162,384

    among all websites

  • Category rank
    #5,101

    Health · Health Conditions and Concerns

Similar websites

Websites whose visitors overlap most with Pendulum. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
myalloy.com
100%
647.4K#57,593View details
als.net
als.net
100%
#803,164–
wiserlifestyles.com
wiserlifestyles.com
95%
#159,826–
gutscharity.org.uk
gutscharity.org.uk
95%
#213,550–
tinyhealth.com
67%
112.2K#263,177View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Pendulum

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Pendulum (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pendulum

Premium access

Complete news archive for Pendulum

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pendulum

Pendulum was founded in 2012 and raised its 1st funding round 5 years after it was founded.

Pendulum is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Pendulum is a funded company, having raised a total of $109.5M across 5 funding rounds to date. The company's 1st funding round was a Series A of $10.5M, raised on Jun 2017.

Pendulum has 55 employees.

Pendulum is engaged in the development of next-generation probiotics aimed at improving whole-body health through gut microbiome transformation. The company operates in the healthcare and biotechnology sector, offering specialized products like Metabolic Daily, Akkermansia, Glucose Control, and Polyphenol Booster. Solutions are backed by scientific research from PhD doctors and scientists, with clinical efficacy demonstrated in products like Glucose Control for type 2 diabetes management. Partnerships with institutions such as the Mayo Clinic and rigorous in-house research further support their innovative approach to microbiome solutions.

Pendulum's top competitors include Sana Biotechnology, Semma Therapeutics and Rezolute.

Pendulum offers Metabolic Daily, Akkermansia, Glucose Control, and Polyphenol Booster.

Pendulum has 8 investors. Key investors include Mayo Clinic, Khosla Ventures, Fonterra, Halle Berry, and Meritech Capital.

The website of Pendulum receives about 265 thousand visits a month and ranks #162,384 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available